诱导性多能干细胞基因模型的疾病演变在髓性白血病:MDS到AML
1Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Advances in biological regulation
|October 5, 2025
概括
诱导多能干细胞 (iPSCs) 和CRISPR基因编辑创建了髓质疏松症候群 (MDS) 和二次急性髓质白血病 (sAML) 的模型. 这些模型促进了对疾病进展的理解,并使个性化治疗药物发现成为可能.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 骨髓发育性综合征 (MDS) 是由血液造血干细胞中累积突变驱动的骨髓性恶性瘤.
- 大约三分之一的MDS患者进展为二次急性髓性白血病 (sAML),预后不佳.
- 诱导多能干细胞 (iPSCs) 为模拟血液恶性瘤提供了一个强大的平台.
研究的目的:
- 利用iPSC技术和CRISPR-Cas9基因编辑来创建MDS的先进细胞模型.
- 调查MDS的遗传和生物异质性及其演变为AML.
- 提高对驱动突变,共突变和疾病进展机制的理解.
主要方法:
- 生成特定阶段的患者iPSC线路.
- 在正常的人类iPSC中进行序列基因编辑,以模仿MDS/AML进展.
- 使用基于iPSC的模型进行高通量药物查.
主要成果:
- 开发各种基于iPSC的细胞模型,反映MDS异质性.
- 通过顺序基因编辑绘制从MDS到AML的进化轨迹.
- 增加对突变对疾病表型和阶段过渡的影响的理解.
结论:
- iPSC 技术和 CRISPR 编辑对于模拟像 MDS 和 sAML.这样的骨髓性恶性瘤至关重要.
- 这些模型为疾病进展和突变效应提供了关键的见解.
- 基于iPSC的平台有助于药物发现和为MDS患者开发个性化疗法.
相关概念视频
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


